Статья
ИНФЕКЦИЯ HELICOBACTER PYLORI, АТЕРОСКЛЕРОЗ И ИШЕМИЧЕСКАЯ БОЛЕЗНЬ СЕРДЦА
Инфекция Helicobacter pylori, атеросклероз и ишемическая болезнь сердца.
1. Аруин Л.И. Helicobacter pylori и предраковые изменения желудка.//Материалы II Международного симпозиума «Диагностика и лечение заболеваний, ассоциированных с Helicobacter pylori». М., 1999. е. 33.
2. Диагностика и лечение инфекции Helicobacter pylori: современные представления. (Доклад Второй конференции по принятию консенсуса в Маастрихте 21-22 сентября 2000 г.).//Российский журнал гастроэнтерологии, гепатологии и колопроктологии. 2000. № 6. C. 86-88.
3. Елагин Р. Инфекция Helicobacter pylori и смертность от ишемической болезни сердца: отрицательные результаты крупного проспективного исследования.//РМЖ.1999. Т. 7, № 3.
4. Исаков В.А., Кудрявцева Л.В. Азитромицин (Сумамед) -новый компонент антихеликобактерной терапии.//Клиническая фармакология и терапия. 2000. Т. 9 (1). C. 22-24.
5. Лапина Т.Л. Эпидемиология инфекции Н. pylori: фокусируя внимание на российских исследованиях.//Материалы II Международного симпозиума «Диагностика и лечение заболеваний, ассоциированных с Helicobacter pylori». М., 1999. е. 5.
6. Панченко Е.П. Механизмы развития острого коронарного синдрома.//Русский медицинский журнал. 2000. Т. 8, № 8.
7. Попонина Т.М., Кавешников B.C., Марков В.А., Карпов P.C. Chlamydia pneumoniae: связь с атеросклерозом и ишемической болезнью сердца.//Кардиология. 2001. № 9. C. 65-69.
8. Рудык Ю.С., Смелянская М.В., Перемот С.Д., Опарин А.Л. Связь Helicobacter pylori с ишемической болезнью сердца.//Украинский химиотерапевтический журнал. 2000. № 3. C. 43-48.
9. Aceti A., Mazzacurati G., Pennica A., et al. H. pylori and C. pneumoniae infections may account for most acute coronary syndromes. BMJ 1996 Aug; 313: 428-9.
10. Ammann P., Marschall S., Kraus M., et al. Characteristics and prognosis of myocardial infarction in patients with normal coronary arteries. Chest 2000 Feb; 117 (2): 333-8.
11. Anderson J.L., Carlquist J.F., Muhlestein J.B., et al. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction. J Am Coll Cardiol 1998 Jul; 32 (1): 35-41.
12. Benitez R.M. Atherosclerosis: an infectious disease? Hosp Pract (Off Ed) 1999 Sep 1; 34 (9): 79-82, 85-6, 89-90.
13. Cammarota G., Cuoco L., Tursi A., et al. Associacion of cytotoxin-associated gene-A positive Helicobacter pylori strains with coro nary heart disease. Xth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Septemer 12-14, 1997, Lisbon, Portugal. Abstr. 13.462.
14. Cammarota G., Pasceri V., Gasbarrini A., Gasbarrini G. Helicobacter pylori is an aetiological factor for ishaemic heart disease: the case against. Dig Liver Dis 2000 Jan-Feb; 32 (1): 65-8.
15. Choussat R., Montalescot G., Collet J., et al. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am J Cardiol 2000 Aug 15; 86(4): 379-84.
16. Famularo G., Trinchieri V., Santini G., De Simone C. Infections, atherosclerosis, and coronary heart disease. Ann Ital Med Int 2000 Apr-Jun; 15(2): 144-55.
17. Farsak В., Yildirir A., Akyon Y., et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000 Dec; 38 (12): 4408-11.
18. Folsom A.R., Nieto F.J., Sorlie P., et al. Helicobacter pylori seropositivity and coronaty heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. Circulation 1998 Sep 1; 98 (9): 845-50.
19. Franceschi F., Sepulveda A.R., Gassbarrini A., et al. Cross-reactivity between anti-CagA antibodies and vascular antigens. XLVth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Strasbourg, 6-8 September, 2001: A 13.05.
20. Galante A., Pietroiusti A., Carta S., et al. Infection with Helicobacter pylori and leukocyte response in patients with myocardial infarction. Eur J Clin Microbiol Infect Dis 2000 Apr; 19 (4): 298-300.
21. Garsia B.J., Martinez M.P., Rodriguez F.M. J., et al. Inflammation and infection in stable coronary disease and the acute coronary syndrome. Rev Esp Cardiol 2001; 54 (4): 453-459.
22. Gassbarrini A., Cremonini F., Armuzzi A., et al. The role of Helicobacter pylori in cardiovascular and cerebrovascular diseases. J Physiol Pharmacol 1999 Dec; 50 (5): 735-42.
23. Grabczewska Z., Nartowicz E. Infections with Chlamidia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis. Przegl Lek 1999; 56 (9): 584-7.
24. Gunn M., Stephens J.C., Thompson J.R., et al. Significant association of CagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000 Sep; 84 (3): 267-71.
25. Gupta S., Camm A.J. Is there an infective aetiology to atherosclerosis? Drags Aging 1998; 13: 1-7.
26. Hishiki S., Shiwa Т., Yokoyama Т., et al. Change of cardiovascular risk factors after eradication therapy of Helicobacter pylori. Nippon Shokakibyo Gakkai Zasshi 2001 Jul; 98 (7): 814-21.
27. Hveem K., Kruger O., Asberg A. The prevalence of Helicobacter pylori infections in general population, its relationship to global health and to cardiovascular risk factors.GUT-Vol. 45, Suppl. III, September 1999, page: A47.
28. Khurshid A., Fenske T., Bajwa T., et al. A prospective, controlled study of Helicobacter pylori seroprevalence in coronary artery disease. Am J Gastroenterol 1998 May; 93 (5): 717-20.
29. Konig В., Wolle K., Ambrosch A., et al. Induction of adhesion molecules and proinflammatory cytokines by Helicobacter pylori -potencial role in atherosclerosis. XIIth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. September 1-4, 1999, Helsinki, Finland; A: 01.11.
30. Konturek P.C., Kowalsky M., Nasseri R., et al. Detection of Helicobacter pylori (Hp) specific DNA in human coronary artery atherosclerotic plaques. XIVth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Strasbourg, 6-8 September, 2001: A 13.02.
31. Kowalski M., Konturek P.C., Pieniazek P., et al. Prevalence of Helicobacter pylori infection in coronary lumen reduction after percutaneous coronary angioplasty. Dig Liver Dis 2001 Apr; 33 (3): 222-9.
32. Laurila A., Bloigu A., Nayha S., et al. Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis 1999 Jan; 142 (1): 207-10.
33. Leinonen M., Saikku P. Infections and atherosclerosis. Scand Cardiovasc. J. 2000; 34 (1): 12-20.
34. Malnick S.D.H., Adlan K., Goland S., et al. High incidence of H Pylori seropositivity in young patients with coronary artery disease.5th United European Gastroenterology Week 2-6 November 1996, Amsterdam; A: P. 14 0378.
35. Muhlestein J.B. Chronic infection and coronary artery disease. Med. Clin. North. Am. 2000 Jan; 84 (1): 123-48.
36. Oderda G., Chiorboli E., Haitink O., et al. Plasma fibrinogen decreases after eradication in children with Helicobacter pylori gastritis. Xth International Workshop on Gastroduodenal Pathology and Helicobacter pylori. Septemer 12-14, 1997, Lisbon, Portugal. A. 07.236.
37. O'Donnell C.J., Levy D. Weighing the evidence for infection as a risk factor for coronary heart disease.Curr. Cardiol. Rep. 2000 Jul; 2(4): 280-7.
38. Osawa H., Kawakami M., Fujii M., et al. Helicobacter pylori infection and coronary heart disease in Japanese patients. Cardiology 2001; 95 (1): 14-9.
39. Paoluzi P., Consolazio A., Borgia Mc., et al. Increased thrombin generation in patients with chronic gastritis and Helicobacter pylori infection. 8th United European Gastroenterology Week 25-30 November 2000, Brussels, Belgium; A: P. 422.
40. Pasceri V., Cammarota G., Patti G., et al. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 1998; 97: 1675-9.
41. Pellicano R., Oliaro E., Gandolfo N., et al. Ischaemic cardiovascular disease and Helicobacter pylori. Where is the link? J. Cardiovasc. Surg. (Torino) 2000 Dec; 41 (6): 829-33.
42. Pieniazek P., Karczewska E., Duda A., et al. Association of Helicobacrter pylori infection with coronary heart disease. J Physiol. Pharmacol. 1999 Dec; 50 (5): 743-51.
43. Saruc M., Yuceuar H. The role of virulent Helicobacter pylori strains in the etiopathogenesis of coronary artery disease.8th United European Gastroenterology Week 25-30 November 2000, Brussels, Belgium; A: P. 383.
44. Schussheim A.E., Fuster V. Antibiotics for myocardial infarction? A possible role of infection in atherogenesis and acute coronary syndromes.Drugs 1999 Mar; 57 (3): 283-91.
45. Stone A. Does Helicobacter pylori cause heart disease. 8th United European Gastroenterology Week 25-30 November 2000, Brussels, Belgium; A: 56.03.
46. Strachan D.P. Non-gastrointestinal consequences of Helicobacter pylori infection.Br Med Bull 1998; 54 (1): 87-93.
47. Vercellotti G.M. Microbes, inflammation and atherosclerosis: will old pathology lessons guide new therapies? Trans Am Clin Climatol Assoc 2001; 112: 215-22; discussion 222-3.
48. Wald N.J., Law M.R., Morris J.K., Bagnall A.M. Helicobacter pylori infection and mortality from ishaemic heart disease: negative result from a large, prospective study. British Medical Journal 1997; 315(7117): 1199-1201.
49. Zellner C., Chou T.M. Antibiotic prophylaxis and treatment of car…